Evidence map›Paper›PMID 28074307›Full record

ArticleClinical and experimental nephrology2017

Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.

Takeshi Ninchoji, Kandai Nozu, Keita Nakanishi, Tomoko Horinouchi, Junya Fujimura, Tomohiko Yamamura, Shogo Minamikawa, Shingo Ishimori, Koichi Nakanishi, Norishige Yoshikawa and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Takeshi NinchojiDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan. nincho@med.kobe-u.ac.jp.
Kandai NozuDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Keita NakanishiDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Tomoko HorinouchiDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Junya FujimuraDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Tomohiko YamamuraDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Shogo MinamikawaDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Shingo IshimoriDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Koichi NakanishiDepartment of Pediatrics, Wakayama Medical University, Wakayama, Japan.
Norishige YoshikawaClinical Research Center, Wakayama Medical University, Wakayama, Japan.
Ichiro MoriokaDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Hiroshi KaitoDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Kazumoto IijimaDepartment of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuo, Kobe, 6500017, Japan.
Kobe University · JPWakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo clarify the clinical characteristics and long-term outcomes of patients with diarrhea-associated hemolytic uremic syndrome (D + HUS) with a particular focus on time course.

methodsWe retrospectively analyzed the medical records of 61 patients with D + HUS who were admitted to Kobe University Hospital between 1995 and 2015. The onset of D + HUS was defined as day 1 of diarrhea.

resultsThe age of onset was 4.1 (1.5-13.4) years, and the period between onset and diagnosis of D + HUS was 5 (3-18) days. The platelet count was lowest on day 7 (4-24), and the lactase dehydrogenase level was maximal on day 8 (4-25). Twenty-three patients required dialysis for 13 (2-37) days, starting at day 5-9. Seventeen patients showed central nervous system (CNS) symptoms at day 4-18. They were followed up for 3.7 (0-18.4) years. At the final follow-up, estimated glomerular filtration rate was 113.7 (57.9-159.9) ml/min/1.73 m

conclusionCNS complications were often apparent after blood examination results improved. Moreover, a shorter period between the onset of diarrhea and a diagnosis of D + HUS indicated a more severe clinical course or long-term sequelae, and it should be considered as a risk factor for poor prognosis.

Indexed as

AdolescentCentral Nervous System DiseasesChildChild, PreschoolDiarrheaDisease ProgressionFemaleGlomerular Filtration RateHemolytic-Uremic SyndromeHospitals, UniversityHumansInfantJapanKidneyMaleMedical RecordsCentral nervous system complicationDialysisHemolytic uremic syndromeKidney dysfunction

Identifiers

PMID28074307
OpenAlexW2568323622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.